Recent studies [16] have shown that the NF-κB signaling pathway was activated in diabetic gastrointestinal motility disorders and the decrease expression of SCF/c-kit causes the increase of ICC apoptosis, suggesting that the activation of NF-κB signaling may be an important factor in ICC apoptosis. Here, KITLG is linked to intrahepatic cholangiocarcinoma.